Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.

Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Abstract Text:

Michael E Pichichero,Angela Gentile,Norberto Giglio,Veronica Umido,Thomas Clarkson,Elsa Cernichiari,Grazyna Zareba,Carlos Gotelli,Mariano Gotelli,Lihan Yan,John Treanor,Michael E Pichichero,Angela Gentile,Norberto Giglio,Veronica Umido,Thomas Clarkson,Elsa Cernichiari,Grazyna Zareba,Carlos Gotelli,Mariano Gotelli,Lihan Yan,John Treanor,Michael E Pichichero,Angela Gentile,Norberto Giglio,Veronica Umido,Thomas Clarkson,Elsa Cernichiari,Grazyna Zareba,Carlos Gotelli,Mariano Gotelli,Lihan Yan,John Treanor,

OBJECTIVES. Thimerosal is a mercurial preservative that was widely used in multidose vaccine vials in the United States and Europe until 2001 and continues to be used in many countries throughout the world. We conducted a pharmacokinetic study to assess blood levels and elimination of ethyl mercury after vaccination of infants with thimerosal-containing vaccines. METHODS. Blood, stool, and urine samples were obtained before vaccination and 12 hours to 30 days after vaccination from 216 healthy children: 72 newborns (group 1), 72 infants aged 2 months (group 2), and 72 infants aged 6 months (group 3). Total mercury levels were measured by atomic absorption. Blood mercury pharmacokinetics were calculated by pooling the data on the group and were based on a 1-compartment first-order pharmacokinetics model. RESULTS. For groups 1, 2, and 3, respectively, (1) mean +/- SD weights were 3.4 +/- 0.4, 5.1 +/- 0.6, and 7.7 +/- 1.1 kg; (2) maximal mean +/- SD blood mercury levels were 5.0 +/- 1.3, 3.6 +/- 1.5, and 2.8 +/- 0.9 ng/mL occurring at 0.5 to 1 day after vaccination; (3) maximal mean +/- SD stool mercury levels were 19.1 +/- 11.8, 37.0 +/- 27.4, and 44.3 +/- 23.9 ng/g occurring on day 5 after vaccination for all groups; and (4) urine mercury levels were mostly nondetectable. The blood mercury half-life was calculated to be 3.7 days and returned to prevaccination levels by day 30. CONCLUSIONS. The blood half-life of intramuscular ethyl mercury from thimerosal in vaccines in infants is substantially shorter than that of oral methyl mercury in adults. Increased mercury levels were detected in stools after vaccination, suggesting that the gastrointestinal tract is involved in ethyl mercury elimination. Because of the differing pharmacokinetics of ethyl and methyl mercury, exposure guidelines based on oral methyl mercury in adults may not be accurate for risk assessments in children who receive thimerosal-containing vaccines.

Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Publishing Authors By Initials

ME Pichichero,A Gentile,N Giglio,V Umido,T Clarkson,E Cernichiari,G Zareba,C Gotelli,M Gotelli,L Yan,J Treanor,ME Pichichero,A Gentile,N Giglio,V Umido,T Clarkson,E Cernichiari,G Zareba,C Gotelli,M Gotelli,L Yan,J Treanor,ME Pichichero,A Gentile,N Giglio,V Umido,T Clarkson,E Cernichiari,G Zareba,C Gotelli,M Gotelli,L Yan,J Treanor,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Pediatrics

VOLUME: 121

Page Numbers: e208-14

Journal Abbreviation: Pediatrics

ISSN: 1098-4275

DAY: 4

MONTH: Feb

YEAR: 2008

Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 376422

Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.

AFFILIATION: University of Rochester Medical Center, 601 Elmwood Ave, Box 672, Rochester, NY 14642. michael_pichichero@urmc.rochester.edu.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Pediatrics

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines Related Publications

• Acute respiratory tract infection in daycare centers for older persons.
• Immune Responses of Healthy Subjects to a Single Dose of Intramuscular Inactivated Influenza A/Vietnam/1203/2004 (H5N1) Vaccine after Priming with an Antigenic Variant.
• Infection-induced proinflammatory cytokines are associated with decreases in positive affect, but not increases in negative affect.
• Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
• Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria.
• Threat interpretation bias as a vulnerability factor in childhood anxiety disorders.
• Viral infections of the respiratory tract: prevention and treatment.